166 related articles for article (PubMed ID: 15154662)
1. Alfa-epoietin and anaemia in gynaecological cancer.
Di Cocco B; Salesi N; Fabi A; Nardoni C; Ferretti G; Bossone G; Ciccarese M; Savarese A; Vecchione A; Cognetti F
Anticancer Res; 2004; 24(2C):1287-92. PubMed ID: 15154662
[TBL] [Abstract][Full Text] [Related]
2. The role of epoetin beta in the treatment of anaemia in patients with gynaecological malignancies.
Cornes P; Boiangiu I
Anticancer Res; 2007; 27(1B):513-22. PubMed ID: 17348435
[TBL] [Abstract][Full Text] [Related]
3. Role of epoetin in the management of anaemia in patients with lung cancer.
Morère JF
Lung Cancer; 2004 Nov; 46(2):149-56. PubMed ID: 15474662
[TBL] [Abstract][Full Text] [Related]
4. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
Biesma B; van de Werf PR; Melissant CF; Brok RG
Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632
[TBL] [Abstract][Full Text] [Related]
5. Epoetin beta therapy in patients with solid tumours.
Pronzato P; Jassem J; Mayordomo J
Crit Rev Oncol Hematol; 2006 Apr; 58(1):46-52. PubMed ID: 16169242
[TBL] [Abstract][Full Text] [Related]
6. The impact and management of anaemia in haematological malignancies.
Coiffier B
Med Oncol; 2000 Nov; 17 Suppl 1():S2-10. PubMed ID: 11188782
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of anaemia in patients with malignancy: implications for the clinical use of recombinant human erythropoietin.
Cazzola M
Med Oncol; 2000 Nov; 17 Suppl 1():S11-6. PubMed ID: 11188780
[TBL] [Abstract][Full Text] [Related]
8. rHuEPO and improved treatment outcomes: potential modes of action.
Blackwell K; Gascón P; Sigounas G; Jolliffe L
Oncologist; 2004; 9 Suppl 5():41-7. PubMed ID: 15591421
[TBL] [Abstract][Full Text] [Related]
9. Prior red blood cell transfusions in cancer patients increase the risk of subsequent transfusions with or without recombinant human erythropoietin management.
Couture F; Turner AR; Melosky B; Xiu L; Plante RK; Lau CY; Quirt I
Oncologist; 2005 Jan; 10(1):63-71. PubMed ID: 15632253
[TBL] [Abstract][Full Text] [Related]
10. rHuEPO and treatment outcomes: the preclinical experience.
Ludwig H
Oncologist; 2004; 9 Suppl 5():48-54. PubMed ID: 15591422
[TBL] [Abstract][Full Text] [Related]
11. [Tumor anemia. Overview of the role of human recombinant erythropoietin (r-hu-EPO) in treatment of tumor anemia].
Monnerat C; Leyvraz S
Praxis (Bern 1994); 1999 Jan; 88(5):178-88. PubMed ID: 10067375
[TBL] [Abstract][Full Text] [Related]
12. rHuEPO and treatment outcomes: the clinical experience.
Hudis CA; Van Belle S; Chang J; Muenstedt K
Oncologist; 2004; 9 Suppl 5():55-69. PubMed ID: 15591423
[TBL] [Abstract][Full Text] [Related]
13. Darbepoetin alfa: new indication/new dosage. No proven advantage in chemotherapy-induced anaemia.
Prescrire Int; 2005 Oct; 14(79):174-6. PubMed ID: 16285072
[TBL] [Abstract][Full Text] [Related]
14. The role of recombinant erythropoietin in childhood cancer.
Shankar AG
Oncologist; 2008 Feb; 13(2):157-66. PubMed ID: 18305061
[TBL] [Abstract][Full Text] [Related]
15. [Summary version of the Standards, Options and Recommendations for the use of recombinant erythropoietin (epoietin-alpha and beta, darbepoietin-alpha, EPO) in the management of anaemia in oncology - Update 2003].
Spaeth D; Casadevall N; Daouphars M; Marchal C; Marec-Berard P; Fabre N; Haugh M;
Bull Cancer; 2004 Feb; 91(2):179-88. PubMed ID: 15047458
[TBL] [Abstract][Full Text] [Related]
16. Treatment of cancer-related anemia.
Badzek S; Curić Z; Krajina Z; Plestina S; Golubić-Cepulić B; Radman I
Coll Antropol; 2008 Jun; 32(2):615-22. PubMed ID: 18756919
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human erythropoietin (rHuEPO) therapy in patients with cancer-related anaemia: what have we learned?
Osterborg A
Med Oncol; 1998 Aug; 15 Suppl 1():S47-9. PubMed ID: 9785337
[No Abstract] [Full Text] [Related]
18. Anemia in multiple myeloma.
Ludwig H; Pohl G; Osterborg A
Clin Adv Hematol Oncol; 2004 Apr; 2(4):233-41. PubMed ID: 16163188
[TBL] [Abstract][Full Text] [Related]
19. The role of recombinant human erythropoietin in the management of anaemic cancer patients: focus on haematological malignancies.
Osterbor A
Med Oncol; 2000 Nov; 17 Suppl 1():S17-22. PubMed ID: 11188781
[TBL] [Abstract][Full Text] [Related]
20. [Anaemia treatment in gynaecology: use of epoetin in onco-gynaecology and gynaecological surgery].
Kirchner V;
Rev Med Suisse; 2005 Apr; 1(15):1041-3, 1046-7. PubMed ID: 15918284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
